AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
JN
Jupiter NeurosciencesClinical-stage biotech developing JOTROL, a proprietary high-bioavailability resveratrol platform targeting neuroinflammation, mitochondrial dysfunction, and longevity indications including Parkinson's and Alzheimer's disease.
1 Pulse story
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
—
Irvine, California
HQ
Jupiter, Florida
Public (AEON)
Status
Public (JUNS)
AEON Biopharma investors
No investors on record.
Jupiter Neurosciences investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Jupiter Neurosciences.